$DBA
INVESCO DB AGRICULTURE FUND

2019 Q4 Form 10-K Financial Statement

#000156459021009013 Filed on February 26, 2021

View on sec.gov

Income Statement

Concept 2019 Q4 2019 2018
Revenue $9.291M $11.60M
YoY Change -19.93% 96.76%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $3.937M $6.056M
YoY Change -34.99% -9.86%
Operating Profit $5.469M $5.667M
YoY Change -3.51% -932.95%
Interest Expense $37.17K $53.02K
YoY Change -29.9% 697.04%
% of Operating Profit 0.68% 0.94%
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings -$7.294M -$64.89M
YoY Change -88.76% 40.32%
Net Earnings / Revenue -78.51% -559.27%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 2018
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $348.0M
YoY Change -30.39%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $244.0K
YoY Change -95.32%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $347.8M
YoY Change
Total Liabilities & Shareholders Equity $348.0M
YoY Change -30.39%

Cashflow Statement

Concept 2019 Q4 2019 2018
OPERATING ACTIVITIES
Net Income -$7.294M -$64.89M
YoY Change -88.76% 40.32%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $143.1M $76.60M
YoY Change 86.76% 116.94%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $5.401M $5.398M
YoY Change 0.04%
Common Stock Issuance & Retirement, Net $134.3M $76.68M
YoY Change 75.13% 117.65%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -142.9M -78.86M
YoY Change 81.21% 123.85%
NET CHANGE
Cash From Operating Activities 143.1M 76.60M
Cash From Investing Activities
Cash From Financing Activities -142.9M -78.86M
Net Change In Cash 161.9K -2.261M
YoY Change -107.16% -2937.25%
FREE CASH FLOW
Cash From Operating Activities $143.1M $76.60M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2018 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
512550
CY2020 us-gaap Distributed Earnings
DistributedEarnings
0
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
641751747
CY2019Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
147718751
CY2020Q4 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
6464955
CY2019Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
200021832
CY2019Q4 us-gaap Receivables From Clearing Organizations
ReceivablesFromClearingOrganizations
62967
CY2020Q4 us-gaap Cash
Cash
6658401
CY2019Q4 us-gaap Assets
Assets
348039419
CY2019Q4 us-gaap Dividends Receivable
DividendsReceivable
73985
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Cash
Cash
161884
CY2019Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
240542
CY2019Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
3480
CY2019Q4 us-gaap Liabilities
Liabilities
244022
CY2019Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
662
CY2019Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
347794735
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
347795397
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
348039419
CY2019Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2019Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
21000000
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.56
CY2019Q4 dba Market Value Per Share
MarketValuePerShare
16.56
CY2020Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.9804
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
635743153
CY2018 us-gaap Interest Expense
InterestExpense
53019
CY2018 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
5490679
CY2018 us-gaap Operating Expenses
OperatingExpenses
6056248
CY2018 dba Operating Expenses Net
OperatingExpensesNet
5935500
CY2020 dba Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
36635
CY2019 dba Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
11336
CY2019 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-42481477
CY2018 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-84633492
CY2019 us-gaap Unrealized Gain Loss On Commodity Contracts
UnrealizedGainLossOnCommodityContracts
29614325
CY2018 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
120748
CY2018 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
14073703
CY2018 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-70559789
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
347795397
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
420849850
CY2020 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
149338839
CY2020 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
271511011
CY2019 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5400580
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
5468641
CY2019 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-42481477
CY2019 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
29718607
CY2019 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
-146986264
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
347795397
CY2018 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
187262346
CY2018 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
263941886
CY2018 dba Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
-76679540
CY2018 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
5398207
CY2018 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-84633492
CY2018 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
14073703
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-64892339
CY2018 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
1224468152
CY2019 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1202731831
CY2018 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1343705445
CY2019 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1138675218
CY2018 dba Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
749503577
CY2019 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
1033470278
CY2018 dba Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
779637410
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
494781661
CY2018 us-gaap Net Income Loss
NetIncomeLoss
-64892339
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1644585
CY2020 us-gaap Realized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
RealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
-28778835
CY2020 us-gaap Unrealized Gain Loss On Marketable Securities Cost Method Investments And Other Investments
UnrealizedGainLossOnMarketableSecuritiesCostMethodInvestmentsAndOtherInvestments
59580445
CY2020Q4 us-gaap Cash
Cash
6658401
CY2019 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-6974031
CY2018 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-9695040
CY2020 dba Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
1810
CY2019 dba Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
35880
CY2018 dba Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-13515
CY2019 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
104282
CY2018 dba Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
183450
CY2019 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
1686490
CY2018 dba Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-2066075
CY2019 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
29704
CY2018 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
10669
CY2019 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-138593
CY2018 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
-65280
CY2019 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
217
CY2018 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-828
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
143067633
CY2018 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
76603110
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
5400580
CY2018 us-gaap Payments Of Dividends
PaymentsOfDividends
5398207
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
89315901
CY2018 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
187262346
CY2019 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
223607356
CY2018 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
263941886
CY2019 dba Increase Decrease In Payable For Amount Due To Custodian
IncreaseDecreaseInPayableForAmountDueToCustodian
-3213714
CY2018 dba Increase Decrease In Payable For Amount Due To Custodian
IncreaseDecreaseInPayableForAmountDueToCustodian
3213714
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-142905749
CY2018 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-78864033
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
6496517
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
161884
CY2018 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2260923
CY2019Q4 us-gaap Cash
Cash
161884
CY2019 us-gaap Interest Paid Net
InterestPaidNet
37166
CY2018 us-gaap Interest Paid Net
InterestPaidNet
53019
CY2006Q3 dba Number Of Series Of Trusts
NumberOfSeriesOfTrusts
7
CY2020 us-gaap Business Acquisition Date Of Acquisition Agreement1
BusinessAcquisitionDateOfAcquisitionAgreement1
2015-02-23
CY2015Q1 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2020 dba Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
CY2020 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2020 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<div style="align:left;"> <table border="0" cellpadding="0" cellspacing="0" style="border-collapse:collapse; width:100%;"> <tr> <td style="width:3.33%;white-space:nowrap" valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">B.</span></p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-weight:bold;font-style:normal;text-transform:none;font-variant: normal;font-family:Times New Roman;font-size:10pt;">Accounting Estimates</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues </p> <p style="margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> </span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">financial statements are issued</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
CY2019 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
115338
CY2018 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
120748
CY2020 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2019 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2018 dba Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
7.00
CY2020Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
71268158
CY2020Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
707011311
CY2019Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
147718751
CY2020 dba Management Fee Per Annum Of Daily Net Assets
ManagementFeePerAnnumOfDailyNetAssets
0.0085
CY2020 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
332336
CY2020 us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5 - Deposits with Commodity Broker and Custodian</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund defines cash as cash held by the Custodian. There were no cash equivalents held by the Fund as of December 31, 2020 and 2019.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the commodity futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements. </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption <span style="font-style:italic;">Due to custodian</span>.</p>
CY2020Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2019Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2020Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
209933439
CY2020Q4 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
89259449
CY2020Q4 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
336550265
CY2020Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
635743153
CY2019Q4 dba Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
79123338
CY2019Q4 dba Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
120898494
CY2019Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
347740583
CY2019Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation
InvestmentOwnedUnrecognizedUnrealizedAppreciation
13955785
CY2019Q4 us-gaap Investment Owned Unrecognized Unrealized Depreciation
InvestmentOwnedUnrecognizedUnrealizedDepreciation
2202345
CY2019Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
11753440
CY2019Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
359494023
CY2020 dba Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2020 dba Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2020 dba Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
CY2020 dba Number Of Shares Redeemable Per Creation Unit
NumberOfSharesRedeemablePerCreationUnit
100000
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.56
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.37
CY2019 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-0.33
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.06
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.21
CY2018 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.16
CY2020 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.43
CY2019 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-0.12
CY2018 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.64
CY2019 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.26
CY2018 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.18
CY2018Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
16.94
CY2019Q4 dba Market Value Per Share
MarketValuePerShare
16.56
CY2018Q4 dba Market Value Per Share
MarketValuePerShare
16.95
CY2017Q4 dba Market Value Per Share
MarketValuePerShare
18.75
CY2020Q4 dba Market Value Per Share
MarketValuePerShare
16.14
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0039
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0130
CY2018 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0088
CY2020 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0086
CY2019 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0091
CY2018 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0092
CY2020 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0094
CY2019 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0094
CY2018 dba Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0094
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0260
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0070
CY2018 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0874
CY2020 dba Return At Market Value
ReturnAtMarketValue
-0.0254
CY2019 dba Return At Market Value
ReturnAtMarketValue
-0.0076
CY2018 dba Return At Market Value
ReturnAtMarketValue
-0.0864
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
29718607
CY2019 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-12762870
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-7294229

Files In Submission

Name View Source Status
0001564590-21-009013-index-headers.html Edgar Link pending
0001564590-21-009013-index.html Edgar Link pending
0001564590-21-009013.txt Edgar Link pending
0001564590-21-009013-xbrl.zip Edgar Link pending
dba-10k_20201231.htm Edgar Link pending
dba-10k_20201231_htm.xml Edgar Link completed
dba-20201231.xsd Edgar Link pending
dba-20201231_cal.xml Edgar Link unprocessable
dba-20201231_def.xml Edgar Link unprocessable
dba-20201231_lab.xml Edgar Link unprocessable
dba-20201231_pre.xml Edgar Link unprocessable
dba-ex231_8.htm Edgar Link pending
dba-ex311_10.htm Edgar Link pending
dba-ex312_11.htm Edgar Link pending
dba-ex321_7.htm Edgar Link pending
dba-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g1cflegdytcv000001.jpg Edgar Link pending
g1cflegdytcv000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending